Literature DB >> 18339612

Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: still a valid treatment in appropriately selected patients.

Timothy R Betts1.   

Abstract

This review explores the current techniques of atrioventricular junction ablation, pacemaker prescription and implant, the role of anti-arrhythmic drugs, long-term outcomes, potential complications and adverse effects (including sudden cardiac death), and how these may be overcome, and examines the alternative strategies that are now available.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339612     DOI: 10.1093/europace/eun063

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

Review 1.  Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.

Authors:  F De Rienzo; R R Gabdoulline; R C Wade; M Sola; M C Menziani
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

Review 2.  Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome.

Authors:  Jason C Rubenstein; James A Roth
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

Review 3.  [Rate versus rhythm control with and without heart failure].

Authors:  Florian Straube; Uwe Dorwarth; Sabine Janko; Ellen Hoffmann
Journal:  Herz       Date:  2008-12       Impact factor: 1.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.